The 2024 Q2 earnings season is in full swing, with today’s results from the big banks kicking the period into a higher gear. Another period of positivity is expected, with the S&P 500 expected to post positive earnings growth yet again. And concerning next week’s docket, several reports, including those from Netflix NFLX, Taiwan Semiconductor TSM, and Johnson & Johnson JNJ should be on investors’ radars. Let’s take a closer look at how each stacks up heading into their respective quarterly releases. Netflix Streaming titan Netflix is scheduled to report its quarterly results on Thursday, July 18, after the market’s close. Shares plunged following its latest earnings release but have since recovered nicely, now trading near all-time highs. As usual, subscriber metrics will be key in the release, though it’s critical to note that the company will no longer report quarterly membership numbers starting next year in 2025 Q1. Concerning its latest release, total subscribers were reported at 269.6 million, reflecting a 16% jump year-over-year. The company’s subscriber additions have consistently exceeded our expectations as of late, chaining together four consecutive beats. Zacks Investment Research Image Source: Zacks Investment Research Earnings and revenue expectations have primarily remained the same, with current estimates alluding to 43% EPS growth on 17% higher sales. The company’s profitability has improved nicely amid operational efficiencies, with margins moving higher over the last few periods. Please note that the chart below is on a trailing twelve-month basis. Zacks Investment Research Image Source: Zacks Investment Research Taiwan Semiconductor TSM shares have benefited nicely on the back of the broader semiconductor trade in 2024, gaining more than 80% and widely outperforming. The AI frenzy has been the primary driver behind the semiconductor trade, with companies racing to arm themselves with AI chips. Earnings expectations for the quarter stayed stagnant for some time but have recently ticked higher, with the $1.37 per share estimate suggesting a 20% climb from the year-ago period. Sales expectations have been more positive, with the $20.2 billion expected up 5% over the same timeframe and alluding to a 29% climb year-over-year. Zacks Investment Research Image Source: Zacks Investment Research It’s worth noting that valuation multiples have expanded amid investors’ expectations of higher growth, with the current 26.5X forward 12-month earnings multiple above the 19.8X five-year median. Still, the current PEG ratio works out to 1.1X, reflecting that investors aren’t overpaying for growth. Zacks Investment Research Image Source: Zacks Investment Research Keep in mind that TSM announced a 10% boost to its payout following the release of its latest results, bringing the quarterly total to $0.45/share. TSM’s commitment to increasingly rewarding shareholders has kept it a favorite among income-focused investors seeking technology and semiconductor exposure. TSM reports on Thursday, July 18, after the market’s close. Johnson & Johnson Consumer staples favorite Johnson & Johnson hasn’t seen its shares do much over the last three years, trading sideways and overall losing 4%. Nonetheless, the company has continued to be a strong earnings performer, exceeding our consensus EPS estimate in ten consecutive releases. Zacks Investment Research Image Source: Zacks Investment Research The earnings estimate revisions trend has been slightly bearish for the upcoming release, with the $2.71 Zacks Consensus EPS estimate down 1% since mid-April. As shown below, the estimate was lowered near the beginning of this July. Revenue expectations have remained the same over the same period, with the $22.4 billion expected suggesting a 12% pullback year-over-year. Zacks Investment Research Image Source: Zacks Investment Research JNJ reports on Wednesday, July 17, before the market opens. Bottom Line With the 2024 Q2 earnings season kicking into a much higher gear next week, there are several reports investors should keep on their radars, including those from Netflix NFLX, Taiwan Semiconductor TSM, and Johnson & Johnson JNJ. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Johnson & Johnson (JNJ):Free Stock Analysis Report Netflix, Inc. (NFLX):Free Stock Analysis Report Taiwan Semiconductor Manufacturing Company Ltd. (TSM):Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research
3 Key Earnings Reports to Watch Next Week
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...